Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Obstet Gynaecol ; 26(5): 448-51, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16846875

ABSTRACT

Three population-based age cohorts (40-, 50- and 60-years old) of women (n = 3,590) were followed up to find out if pregnancies, use of oral contraceptives (OCs) or hormone replacement therapy (HRT) affect the appearance of varicose veins. Results were presented as odds ratios (OR) of prevalences at entry (POR) and as incidence odds ratios (IOR) during the 5-year follow-up. Parity with three or more births was an independent risk factor for varicose veins IOR 2.0 (95% confidence interval (CI), 1.0 - 3.9). OC use showed a small and not significant protective effect for varicose veins, both POR and IOR equal to 0.9. HRT use indicated an increased risk of varicose veins, with POR 1.3 (1.0 - 1.7), but in the follow-up, the effect disappeared, IOR 1.0 (0.5 - 1.9). As a conclusion, higher age and high parity are characteristic for varicose veins. The use of HRT or OCs do not increase the risk.


Subject(s)
Contraceptives, Oral/adverse effects , Estrogen Replacement Therapy/adverse effects , Parity , Varicose Veins/etiology , Adult , Female , Finland/epidemiology , Humans , Incidence , Middle Aged , Pregnancy , Risk Factors , Varicose Veins/epidemiology
2.
Vasa ; 33(3): 159-63, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15461068

ABSTRACT

BACKGROUND: Incidence of varicose veins in the population is unknown. The study aimed at estimating the incidence of varicose veins in complete cohorts of 40-60 year-olds in a general population. PATIENTS AND METHODS: The study was conducted in the city of Tampere, Finland. A validated questionnaire (with 93% sensitivity and 92% specificity) was used in a general population of 6874 individuals (aged 40, 50 or 60). Initially, 3065 of them had no varicose veins and 78% were followed-up for 5 years. RESULTS: 157 individuals reported new varicose veins during the follow-up. The overall incidence was 13.5 per 1000 person years (8.5 for men and 19.2 for women). Female sex was an independent and statistically significant risk indicator of varicose veins (adjusted odds ratio, OR 2.4). The incidence was significantly higher at the age of 50-55 years (OR 1.6). Higher body mass index seemed to be related to higher risk of new varicose veins (OR 1.2-1.8), but the association failed to reach statistical significance. The level of education did not affect the incidence. CONCLUSIONS: New varicose veins appear also in the middle-aged population, and the rate is linked with the female gender, especially at the beginning of the 6th decade.


Subject(s)
Risk Assessment/methods , Urban Population/statistics & numerical data , Varicose Veins/epidemiology , Adult , Age Distribution , Aged , Body Mass Index , Cohort Studies , Data Collection , Educational Status , Female , Finland/epidemiology , Humans , Incidence , Male , Middle Aged , Prevalence , Risk Factors , Sex Distribution
SELECTION OF CITATIONS
SEARCH DETAIL